Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Keeping Track: Two Melanoma Approvals; Pfizer Discloses Retacrit Complete Response

Executive Summary

The latest drug development news and highlights from our FDA Performance Tracker.


Related Content

Bristol Offers Yervoy For Free In New Early Melanoma Indication
Amgen’s Imlygic Approval A Milestone For Oncolytic Cancer Vaccines


Related Companies